| UniProt ID | CLPX_HUMAN | |
|---|---|---|
| UniProt AC | O76031 | |
| Protein Name | ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial | |
| Gene Name | CLPX | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 633 | |
| Subcellular Localization | Mitochondrion. Mitochondrion matrix, mitochondrion nucleoid. | |
| Protein Description | ATP-dependent specificity component of the Clp protease complex. Hydrolyzes ATP. Targets specific substrates for degradation by the Clp complex. [PubMed: 11923310] | |
| Protein Sequence | MPSCGACTCGAAAVRLITSSLASAQRGISGGRIHMSVLGRLGTFETQILQRAPLRSFTETPAYFASKDGISKDGSGDGNKKSASEGSSKKSGSGNSGKGGNQLRCPKCGDLCTHVETFVSSTRFVKCEKCHHFFVVLSEADSKKSIIKEPESAAEAVKLAFQQKPPPPPKKIYNYLDKYVVGQSFAKKVLSVAVYNHYKRIYNNIPANLRQQAEVEKQTSLTPRELEIRRREDEYRFTKLLQIAGISPHGNALGASMQQQVNQQIPQEKRGGEVLDSSHDDIKLEKSNILLLGPTGSGKTLLAQTLAKCLDVPFAICDCTTLTQAGYVGEDIESVIAKLLQDANYNVEKAQQGIVFLDEVDKIGSVPGIHQLRDVGGEGVQQGLLKLLEGTIVNVPEKNSRKLRGETVQVDTTNILFVASGAFNGLDRIISRRKNEKYLGFGTPSNLGKGRRAAAAADLANRSGESNTHQDIEEKDRLLRHVEARDLIEFGMIPEFVGRLPVVVPLHSLDEKTLVQILTEPRNAVIPQYQALFSMDKCELNVTEDALKAIARLALERKTGARGLRSIMEKLLLEPMFEVPNSDIVCVEVDKEVVEGKKEPGYIRAPTKESSEEEYDSGVEEEGWPRQADAANS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 29 | Phosphorylation | ASAQRGISGGRIHMS HHHHHCCCCCCCCHH | 37.71 | 24719451 | |
| 36 | Phosphorylation | SGGRIHMSVLGRLGT CCCCCCHHHHCCCCC | 10.46 | 24719451 | |
| 43 | Phosphorylation | SVLGRLGTFETQILQ HHHCCCCCHHHHHHH | 23.92 | 24719451 | |
| 66 | Phosphorylation | ETPAYFASKDGISKD CCCCEECCCCCCCCC | 22.75 | - | |
| 67 | Ubiquitination | TPAYFASKDGISKDG CCCEECCCCCCCCCC | 57.45 | - | |
| 71 | Phosphorylation | FASKDGISKDGSGDG ECCCCCCCCCCCCCC | 30.17 | - | |
| 80 | Ubiquitination | DGSGDGNKKSASEGS CCCCCCCCCCCCCCC | 54.34 | - | |
| 81 | Ubiquitination | GSGDGNKKSASEGSS CCCCCCCCCCCCCCC | 56.08 | - | |
| 89 | Ubiquitination | SASEGSSKKSGSGNS CCCCCCCCCCCCCCC | 53.29 | - | |
| 90 | Ubiquitination | ASEGSSKKSGSGNSG CCCCCCCCCCCCCCC | 63.10 | - | |
| 98 | Acetylation | SGSGNSGKGGNQLRC CCCCCCCCCCCCEEC | 64.56 | 20167786 | |
| 145 | Phosphorylation | SEADSKKSIIKEPES EHHHHCCCCCCCHHH | 33.03 | 24719451 | |
| 152 | O-linked_Glycosylation | SIIKEPESAAEAVKL CCCCCHHHHHHHHHH | 43.42 | 30379171 | |
| 178 | Acetylation | KIYNYLDKYVVGQSF HHHHHHHHHHHCHHH | 37.03 | 19608861 | |
| 179 | Phosphorylation | IYNYLDKYVVGQSFA HHHHHHHHHHCHHHH | 10.47 | 28258704 | |
| 187 | Methylation | VVGQSFAKKVLSVAV HHCHHHHHHHHHHHH | 41.21 | - | |
| 187 | 2-Hydroxyisobutyrylation | VVGQSFAKKVLSVAV HHCHHHHHHHHHHHH | 41.21 | - | |
| 217 | Ubiquitination | RQQAEVEKQTSLTPR HHHHHHHHHCCCCHH | 65.14 | - | |
| 220 | Phosphorylation | AEVEKQTSLTPRELE HHHHHHCCCCHHHHH | 27.96 | 23403867 | |
| 222 | Phosphorylation | VEKQTSLTPRELEIR HHHHCCCCHHHHHHH | 21.77 | - | |
| 239 | Ubiquitination | EDEYRFTKLLQIAGI HHHHHHHHHHHHCCC | 44.48 | - | |
| 269 | Ubiquitination | NQQIPQEKRGGEVLD HHHCCHHHCCCCCCC | 51.61 | - | |
| 270 | Methylation | QQIPQEKRGGEVLDS HHCCHHHCCCCCCCC | 58.56 | - | |
| 277 | Phosphorylation | RGGEVLDSSHDDIKL CCCCCCCCCCCCCEE | 25.97 | 26471730 | |
| 278 | Phosphorylation | GGEVLDSSHDDIKLE CCCCCCCCCCCCEEC | 30.51 | 26471730 | |
| 286 | Ubiquitination | HDDIKLEKSNILLLG CCCCEECCCCEEEEC | 60.27 | - | |
| 286 | 2-Hydroxyisobutyrylation | HDDIKLEKSNILLLG CCCCEECCCCEEEEC | 60.27 | - | |
| 287 | Phosphorylation | DDIKLEKSNILLLGP CCCEECCCCEEEECC | 21.52 | 20068231 | |
| 295 | Phosphorylation | NILLLGPTGSGKTLL CEEEECCCCCCHHHH | 42.03 | 20068231 | |
| 297 | Phosphorylation | LLLGPTGSGKTLLAQ EEECCCCCCHHHHHH | 39.33 | 20068231 | |
| 299 | Ubiquitination | LGPTGSGKTLLAQTL ECCCCCCHHHHHHHH | 37.38 | - | |
| 300 | Phosphorylation | GPTGSGKTLLAQTLA CCCCCCHHHHHHHHH | 30.45 | - | |
| 349 | Ubiquitination | DANYNVEKAQQGIVF HCCCCHHHHHCCEEE | 47.41 | - | |
| 362 | Ubiquitination | VFLDEVDKIGSVPGI EEEECCCCCCCCCCC | 54.89 | - | |
| 373 | Methylation | VPGIHQLRDVGGEGV CCCCEECCCCCCHHH | 29.96 | - | |
| 386 | Ubiquitination | GVQQGLLKLLEGTIV HHHHHHHHHHCCCEE | 56.95 | - | |
| 398 | Ubiquitination | TIVNVPEKNSRKLRG CEEECCCCCCCHHCC | 54.90 | - | |
| 398 | Acetylation | TIVNVPEKNSRKLRG CEEECCCCCCCHHCC | 54.90 | 25953088 | |
| 407 | Phosphorylation | SRKLRGETVQVDTTN CCHHCCCEEEECCCC | 21.04 | 29978859 | |
| 412 | Phosphorylation | GETVQVDTTNILFVA CCEEEECCCCEEEEE | 23.92 | 28258704 | |
| 413 | Phosphorylation | ETVQVDTTNILFVAS CEEEECCCCEEEEEC | 18.79 | 28258704 | |
| 420 | Phosphorylation | TNILFVASGAFNGLD CCEEEEECCHHCCHH | 25.92 | 29978859 | |
| 437 | Acetylation | ISRRKNEKYLGFGTP HHHCCCCCCCCCCCC | 55.99 | 19608861 | |
| 437 | Ubiquitination | ISRRKNEKYLGFGTP HHHCCCCCCCCCCCC | 55.99 | 19608861 | |
| 438 | Phosphorylation | SRRKNEKYLGFGTPS HHCCCCCCCCCCCCC | 13.09 | 23684312 | |
| 443 | Phosphorylation | EKYLGFGTPSNLGKG CCCCCCCCCCCCCCH | 22.68 | 16964243 | |
| 445 | Phosphorylation | YLGFGTPSNLGKGRR CCCCCCCCCCCCHHH | 44.52 | 29396449 | |
| 449 | Malonylation | GTPSNLGKGRRAAAA CCCCCCCCHHHHHHH | 53.03 | 26320211 | |
| 449 | Ubiquitination | GTPSNLGKGRRAAAA CCCCCCCCHHHHHHH | 53.03 | - | |
| 475 | Acetylation | THQDIEEKDRLLRHV CCCCHHHHHHHHHHH | 35.04 | 23749302 | |
| 512 | Ubiquitination | PLHSLDEKTLVQILT ECCCCCCCHHHHHHH | 46.99 | - | |
| 529 | Phosphorylation | RNAVIPQYQALFSMD CCCCCHHHHHHHCCC | 7.15 | 22817900 | |
| 548 | Ubiquitination | NVTEDALKAIARLAL CCCHHHHHHHHHHHH | 39.19 | - | |
| 591 | Acetylation | IVCVEVDKEVVEGKK EEEEEECHHHHCCCC | 58.55 | 19828841 | |
| 597 | Acetylation | DKEVVEGKKEPGYIR CHHHHCCCCCCCCCC | 40.22 | 19828849 | |
| 607 | Phosphorylation | PGYIRAPTKESSEEE CCCCCCCCCCCCHHH | 46.59 | 28450419 | |
| 610 | Phosphorylation | IRAPTKESSEEEYDS CCCCCCCCCHHHHHC | 44.60 | 23927012 | |
| 611 | Phosphorylation | RAPTKESSEEEYDSG CCCCCCCCHHHHHCC | 50.55 | 25159151 | |
| 615 | Phosphorylation | KESSEEEYDSGVEEE CCCCHHHHHCCCCCC | 20.77 | 30576142 | |
| 617 | Phosphorylation | SSEEEYDSGVEEEGW CCHHHHHCCCCCCCC | 43.78 | 28355574 | |
| 633 | Phosphorylation | RQADAANS------- CCHHHCCC------- | 36.55 | 21406692 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CLPX_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CLPX_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CLPX_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CLPP_HUMAN | CLPP | physical | 11923310 | |
| CH10_HUMAN | HSPE1 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-178 AND LYS-437, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-617, AND MASSSPECTROMETRY. | |